1982
DOI: 10.1016/0221-8747(82)90013-3
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
27
0
2

Year Published

1984
1984
2002
2002

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 123 publications
(30 citation statements)
references
References 17 publications
1
27
0
2
Order By: Relevance
“…This difficulty was well illustrated by conflicting results recently published by authors who tried to relate bone resorbing activity measured in vitro to the presenting features of myeloma patients (especially the extent of bone lesions and disease activity) (Schecter et al, 1980;Durie et al, 1981). Other explanations of these discrepancies could be that some myeloma patients have a very indolent disease at diagnosis in spite of lesions on bone radiography (Alexanian, 1980) (Delmas et al, 1982). In future, the early detection of myeloma patients with very active bone resorption will be necessary, as a rational prerequisite for the combination of anticancer and antiosteoclastic drugs as a primary treatment of MM.…”
mentioning
confidence: 99%
“…This difficulty was well illustrated by conflicting results recently published by authors who tried to relate bone resorbing activity measured in vitro to the presenting features of myeloma patients (especially the extent of bone lesions and disease activity) (Schecter et al, 1980;Durie et al, 1981). Other explanations of these discrepancies could be that some myeloma patients have a very indolent disease at diagnosis in spite of lesions on bone radiography (Alexanian, 1980) (Delmas et al, 1982). In future, the early detection of myeloma patients with very active bone resorption will be necessary, as a rational prerequisite for the combination of anticancer and antiosteoclastic drugs as a primary treatment of MM.…”
mentioning
confidence: 99%
“…1977 and has been used to prevent bone loss in multiple myeloma [Siris et al. 1980;Delmas et al. 1982], Paget's disease [Meunier etal.. 1979;Adami etal., 1984] and experimental osteopor osis [Michael et al.…”
Section: Introductionmentioning
confidence: 99%
“…The fact that the distribution of TBV in our population of MM was normal and that 2 of these patients did not have any myeloma cells in their UTBB would indicate an osteoporosis accidentally associated with haematological disease (see below), leading to therapy other than chemotherapy. In spite of the fact that sodium fluoride, calcium and vitamin D did not improve a large population of MM (Cohen et al, 1984), this special subset of patients could take advantage of this type of specific treatment, perhaps alternating with antiosteoclastic drugs such as diphosphonates, already proven useful in MM (Delmas et al, 1982;Radl et al, 1985). The opposite feature (i.e.…”
mentioning
confidence: 99%